Latest period
$55.97M
YoY change
+48.5%
5Y CAGR
+36.7%
Peak year (2019)
$42.27M
Cumulative CapEx
$184.08M
CapEx history chart for Insmed (INSM) from 1999 to 2025
Latest: $32.56M
CapEx growth chart for Insmed (INSM) from 1999 to 2025
Latest: +48.5%
CapEx history table for Insmed (INSM) from 1999 to 2025
| 2025 | $32.56M | +48.5% | +$10.64M | ||
| 2024 | $21.92M | +65.0% | +$8.63M | ||
| 2023 | $13.29M | +34.5% | +$3.41M | ||
| 2022 | $9.88M | +35.5% | +$2.59M | ||
| 2021 | $7.29M | +6.8% | +$467.00K | ||
| 2020 | $6.82M | -83.9% | −$35.45M | ||
| 2019 | $42.27M | +185.3% | +$27.45M | ||
| 2018 | $14.81M | +393.6% | +$11.81M | ||
| 2017 | $3.00M | -28.5% | −$1.20M | ||
| 2016 | $4.20M | +21.6% | +$746.00K | ||
| 2015 | $3.45M | -35.5% | −$1.90M | ||
| 2014 | $5.35M | +547.8% | +$4.53M | ||
| 2013 | $826.00K | +184.8% | +$536.00K | ||
| 2012 | $290.00K | -70.4% | −$689.00K | ||
| 2011 | $979.00K | -85.5% | −$5.75M | ||
| 2010 | $6.73M | — | +$6.73M | ||
| 2009 | $0.00 | — | $0.00 | ||
| 2008 | $0.00 | — | $0.00 | ||
| 2007 | $0.00 | -100.0% | −$5.02M | ||
| 2006 | $5.02M | — | +$5.02M | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | -100.0% | −$251.00K | ||
| 2002 | $251.00K | 0.0% | $0.00 | ||
| 2001 | $251.00K | -80.6% | −$1.04M | ||
| 2000 | $1.29M | +1083.1% | +$1.18M | ||
| 1999 | $109.38K | — | — |
- 2025$32.56M+48.5%
- 2024$21.92M+65.0%
- 2023$13.29M+34.5%
- 2022$9.88M+35.5%
- 2021$7.29M+6.8%
- 2020$6.82M-83.9%
- 2019$42.27M+185.3%
- 2018$14.81M+393.6%
- 2017$3.00M-28.5%
- 2016$4.20M+21.6%
- 2015$3.45M-35.5%
- 2014$5.35M+547.8%
- 2013$826.00K+184.8%
- 2012$290.00K-70.4%
- 2011$979.00K-85.5%
- 2010$6.73M—
- 2009$0.00—
- 2008$0.00—
- 2007$0.00-100.0%
- 2006$5.02M—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00-100.0%
- 2002$251.00K0.0%
- 2001$251.00K-80.6%
- 2000$1.29M+1083.1%
- 1999$109.38K—
CapEx values are taken from Insmed's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Insmed (INSM)
According to Insmed's latest reported financial statements, the company's current CapEx (TTM) is $55.97M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Insmed (INSM) CapEx totalled $32.56M – surged 48.5% year-over-year.
Over 2020–2025 (5 years), Insmed CapEx expanded at a +36.7% compound annual rate, sustaining 5 straight years of year-over-year growth.
Between 2019 and 2025, Insmed CapEx declined 23.0%, falling from $42.27M to $32.56M.
Across the available history, CapEx reached its high of $42.27M in 2019 and its low of $0.00 in 2003.
Insmed Capital Expenditures by Year
Insmed Capital Expenditures 2025: $32.56M
Insmed CapEx in 2025 was $32.56M, surged 48.5% from 2024.
Insmed Capital Expenditures 2024: $21.92M
2024's CapEx for Insmed came in at $21.92M, surged 65.0% from 2023.
Insmed Capital Expenditures 2023: $13.29M
Insmed posted CapEx of $13.29M in 2023, surged 34.5% from 2022.
Insmed Capital Expenditures 2022: $9.88M
In 2022, Insmed reported CapEx of $9.88M, surged 35.5% from 2021.
Insmed Capital Expenditures 2021: $7.29M
Insmed CapEx in 2021 was $7.29M.
See more financial history for Insmed (INSM).
Sector peers by CapEx
Healthcare peers of Insmed (INSM), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Insmed (INSM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation